Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2005-03-08
2005-03-08
Jones, Dwayne (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S213010, C514S219000, C514S224200, C514S558000, C514S560000
Reexamination Certificate
active
06864288
ABSTRACT:
Novel inhibitors of polyisoprenyl phosphate signaling regulates phopholipase D activity.
REFERENCES:
patent: 5441951 (1995-08-01), Serhan
patent: 5648512 (1997-07-01), Serhan
patent: 6353026 (2002-03-01), Serhan
patent: 6720354 (2004-04-01), Serhan
patent: WO 9429262 (1994-12-01), None
patent: WO 9501179 (1995-01-01), None
patent: WO 0054767 (2000-09-01), None
Olson et al., “Biochemistry and cell biology of phospholipase D in human neutrophils”, Chemistry and Physics of Lipids, 80, pp. 3-19, 1996.*
Takano et al., “Neutrophil-mediated Changes in Vascular Permeability Are Inhibited by Topical Application of Aspirin-triggered 15-epi-lipoxin A4 and Novel Lipoxin B4 Stable Analogues”, J. Clin. Invest. vol. 101, No. 4, Feb. 1998, pp. 819-826.*
Lloyd, A.R. et al., 1992. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunology Today 13:169-172.*
Weissmann, G., Smolen, J. E., and Korchak, H. M. (1980) Release of inflammatory mediators from stimulated neutrophils.N. Engl. J. Med.303, 27-34.
Serhan, C. N., Haeggstrom, J. Z., and Leslie, C. C. (1996) Lipid mediator networks in cell signaling: update and impact of cytokines.FASEB J.10, 1147-1158.
Weiss, S. J. (1989) Tissue destruction by neutrophils,N. Engl. J. Med.320, 365-376.
Serhan, C. N. (1994) Lipoxin biosynthesis and its impact in inflammatory and vascular events.Biochem. Biophys. Acta1212, 1-25.
Borgeat, P., and Naccache, P. H. (1990) Biosynthesis and biological activity of leukotriene B4.Clin. Biochem.23, 459-468.
Yokomizo, T., Izumi, T., Chang, K., Takuwa, T., and Shimizu, T. (1997) A G-protein-coupled receptor for leukotriene B4that mediates chemotaxis.Nature387, 620-624.
Fiore, S., Romano, M., Reardon, E. M., and Serhan, C. N. (1993) Induction of functional lipoxin A4receptors in HL-60 cells.Blood81, 3395-3403.
Isakson, P., Seibert, K., Masferrer, J., Salvemini, D., Lee, L., and Needleman, P. (1995) Discovery of a better aspirin.Advances in Prostaglandin, Thromboxane&Leukotriene Research23, 49-54.
Chiang, N., Takano, T., Clish, C. B., Petasis, N. A., Tai, H.-H., and Serhan, C. N. (1998) Aspirin-triggered 15-epi-lipoxin A4(ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4ELISA.J. Pharmacol Exper. Ther.287, 779-790.
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., and Madara, J. L. (1995) Design of lipoxin A4stable analogs that block transmigration and adhesion of human neutrophils.Biochemistry34, 14609-14615.
Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., and Serhan, C. N. (1997) Aspirin-triggered 15-epi-lipoxin A4(LXA4) and LXA4Stable analogues are potent inhibitors of acute inflammation: Evidence for anti-inflammatory receptors.J. Exp. Med.185, 1693-1704.
Owman, C., Garzino-Demo, A., Cocchi, F., Popovic, M., Sabirsh, A., and Gallo, R. (1998) The leukotriene B4receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells.Proc. Natl. Acad. Sci.95, 9530-9534.
Marcus, A. J. (1995) Aspirin as prophylaxis against colorectal cancer.N. Engl. J. Med.333, 656-658.
Vainio, H., and Morgan, G. (1997) Aspirin for the second hundred years: new uses for an old drug.Pharmacol Toxicol81, 151-152.
Herschman, H. R. (1998) Recent progress in the cellular and molecular biology of phostaglandin synthesis.Trends in Cardiovasc. Med.8, 145-150.
Takano, T., Clish, C. B., Gronert, K., Petasis, N., and Serhan, C. N. (1998) Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4and novel lipoxin B4stable analogues.J. Clin. Invest.101, 819-826.
Billah, M. M., Eckel, S., Mullmann, T. J., Egan, R. W., and Siegel, M. I. (1989) Phosphatidylcholine hydrolysis by phospholipase D determines phosphatidate and diglyceride levels in chemotactic peptide-stimulated human neutrophils. Involvement of phsophatidate Phosphohydrolase in signal transduction.J. Biol. Chem.264, 17069-17077.
Wakelam, M. J. O., Martin, A., Hodgkin, M. N., Brown, F., Pettit, T. R., Cross, M. J., De Takats, P. G., and Reynolds, J. L. (1997) Role and regulation of phospholipase D activity in normal and cancer cells.Advances in Enzyme Regulation37, 29-34.
Olson, S. C., and Lambeth, J. D. (1996) Biochemistry and cell biology of phospholipase D in human neutrophils.Chem. Phys. Lipids80, 3-19.
Steed, P. M., Clark, K. L., Boyar, W. C., and Lasala, D. J. (1998) Characterization of human PLD2 and the analysis of PLD isoform splice variants.FASEB J.12, 1309-1317.
Martin, A., Saqib, K. M., Hodgkin, M. N., Brown, F. D., Pettit, T. R., Armstrong, S., and Wakelam, M. J. O. (1997) Role and regulation of phospholipase D signalling.Biochem. Soc. Trans.25, 1157-1160.
Levy, B. D., Petasis, N. A., and Serhan, C. N. (1997) Polyisoprenyl phosphates in intracellular signalling.Nature389, 985-989.
Agwu, D. E., McPhail, L. C., Sozzani, S., Bass, D. A., and McCall, C. E. (1991) Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase.J. Clin. Invest.88, 531-539.
Pettit, T. R., Martin, A., Horton, T., Liossis, C., Lord, J. M., and Wakelam, M. J. O. (1997) Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions.J. Biol. Chem.272, 17354-17359.
Gomez-Cambronero, J. (1995) Immunoprecipitation of a phospholipase D activity with antiphosphotyrosine antibodies.J. Interferon Cytokine Res.15, 877-885.
Abousalham, A., Riviere, M., Teissere, M., and Verger, R. (1993) Improved purification and biochemical characterization of phospholipase D from cabbage.Biochim. Biophys. Acta1158, 1-7.
Zhou, H.-L., Chabot-Fletcher, M., Foley, J. J., Sarau, H. M., Tzimas, M. N., Winkler, J. D., and Torphy, T. J. (1993) Association between leukotriene B4-induced phospholipase D activation and degranulation of human neutrophils.Biochem. Pharmacol.46, 139-148.
Shechter, I., Fogelman, A. M., and Popjak, G. (1980) A deficiency of mixed function oxidase activities in the cholesterol biosynthetic pathway of human granulocytes.J. Lipid Res.21, 277-283.
Rabinowitz, J. L., Baker, D. G., Villanueva, T. G., Asanza, A. P., and Capuzzi, D. M. (1992) Liver lipid profiles of adults taking therapeutic doses of aspirin.Lipids27, 311-314.
Claria, J., and Serhan, C. N. (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.Proc. Natl. Acad. Sci.92, 9475-9479.
Serhan, C. N. (1997) Lipoxins and Novel Aspirin-Triggered 15-epi-Lipoxins: A Jungle of Cell-Cell Interactions or a Therapeutic Opportunity?Prostaglandins53, 107-137.
Exton, J. H. (1997) New developments in phospholipase D.J. Biol. Chem.272, 15579-15582.
Fensome, A., Whatmore, J., Morgan, C., Jones, D., and Cockcroft, S. (1998) ADP-ribosylation factor and Rho proteins mediate fMLP-dependent activation of phospholipase D in human neutrophils.J. Biol. Chem.273, 13157-13164.
Jarstfer, M. B., Blagg, B. S. J., Rogers, D. H., and Poulter, C. D. (1996) Biosynthesis of squalene. Evidence for a tertiary cyclopropylcarbinyl cationic intermediate in the rearrangement of presqualene diphosphate to squalene.J. Amer. Chem. Soc.118, 13089-13090.
Bach, T. J. (1995) Some new aspects of isoprenoid biosynthesis in plants—a review.Lipids30, 191-202.
Serhan et al., “Aspirin-Triggered 15-EPI-Lipoxin A4and Novel Lipoxin B4Stable Analogs Inhibit Neutrophil-Mediated Changes In Vascular Permeability”,Advances in Experimental Medicine and Biology, vol. 469, 1999, pp. 287-293.
Gewirzt et al., “Pathogen-Induced Chemokine Secrection from Model Intestinal Epithelium is Inhibited by Lipoxin A4Analogs”,Journal of Clinical Investigation, vol. 101, No. 9, May 1998, pp. 1860-1869.
Hansson et al., “Activation of Protein Kinase C By Lipoxin A and Other Eicosanoids. Intracellular Action of Oxygenation Products of Arachidonic Acid”,Biochemical
Brigham & Women's Hospital Inc.
Dorsey & Whitney LLP
Jones Dwayne
Rothenberger Scott D.
LandOfFree
Regulation of phospholipase D activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of phospholipase D activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of phospholipase D activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3389385